Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Myopia
Share your love
CCOI Myopia Workshop: Michael X. Repka, MD, MBA, on building consensus and future directions – Ophthalmology Times
CCOI Myopia Workshop: Michael X. Repka, MD, MBA, on building consensus and future directions Ophthalmology Times Source: Author: | Date: 2025-08-27 13:49:00 Source: Author: | Date: 2025-08-27 13:49:00
Michael X. Repka, MD, MBA, on building consensus and future directions
In advance of the upcoming CCOI Myopia Workshop, scheduled for September 8 in Paris, France, Michael X. Repka, MD, MBA—program co-chair of the event and current president of the American Academy of Ophthalmology—spoke about the challenges and opportunities facing the…
Next-generation IOLs advance complex cataract care
(Image Credit: AdobeStock/Mohammed) Cataract surgery in patients who have previously undergone refractive procedures, such as LASIK or radial keratotomy (RK), presents unique challenges, noted Steven J. Dell, MD, medical director of Dell Laser Consultants in Austin, Texas, during an Ophthalmology…
Possible protective role of cannabis in preventing postoperative proliferative vitreoretinopathy after retinal detachment repair
(Image credit: AdobeStock/yellowj) Long-term cannabis use might play a role in reducing proliferative vitreoretinopathy (PVR) development,1 according to first author Ahmed M. Alshaikhsalama, MD. He is from the Department of Ophthalmology, University of Texas Southwestern Medical Center, Dallas. He and…
OCT changes with low-level red light therapy for myopia in children
(Image credit: AdobeStock/Microgen) Zhehuan Zhang, MD, and colleagues from the Department of Ophthalmology, Children’s Hospital of Fudan University, National Children’s Medical Center, Shanghai, emphasized the importance of patients undergoing routine optical coherence tomography (OCT) scans during repeated low-level red-light (RLRL)…
OCT changes with low-level red light therapy for myopia in children – Ophthalmology Times
OCT changes with low-level red light therapy for myopia in children Ophthalmology Times Source: Author: | Date: 2025-08-26 11:22:00 Source: Author: | Date: 2025-08-26 11:22:00
The emerging era of presbyopia-correcting eye drops: What’s next?
(Image Credit: AdobeStock/taffpixture) Since 2021, only 1 prescription eye drop for the correction of presbyopia, pilocarpine HCI ophthalmic solution 1.25% (Vuity; AbbVie), has been available, with additional options expected soon. In early 2025, a second eye drop, pilocarpine HCI ophthalmic…
AEVR’s executive director on #SeeWhatMatters and safeguarding the National Eye Institute
#SeeWhatMatters is a national advocacy campaign to raise awareness about the importance of federally funded vision research and to protect the independence of the National Eye Institute amid proposed structural changes to the NIH. (Image courtesy of #SeeWhatMatters) The Alliance…
Lifestyle and sleep-related behaviours in children with myopia – BMC Ophthalmology
Lifestyle and sleep-related behaviours in children with myopia BMC Ophthalmology Source: Author: | Date: 2025-02-26 08:00:00 Source: Author: | Date: 2025-02-26 08:00:00
FDA Greenlights Phase 1 Trial for IOPCL Magnifier
OnPoint Vision has officially received FDA approval for their investigational device exemption (IDE) application, initiating the phase 1 in the pivotal clinical trial for the AccuraSee Intraocular Pseudophakic Capsular Lens (IOPCL) Magnifier (MAG). This trial focuses on the secondary implantation…